my resting rate went up 3 bpm in the first month and came back most of the way by month 13, ymmv
#retatrutide 2025-09-27
Saturday34 messages8 participantstimes are UTC
Highlights from this day
- snac_and_water — TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule 13:13
- maintenance_mo — appetite suppression at 15 was stronger than my tirzepatide experience at a comparable point 13:19
- snac_and_water — the honest position is this has less human evidence behind it than anything else discussed here, your mileage will differ 17:56
TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule
📈18⚠️4✅1
low and slow here means smaller steps than i ever used on tirzepatide, thats the received wisdom
🧊9🙏1
watching my heart rate
🎉1
held at 15 for 12 months and it never plateaued for me, which i cant explain
🎉15🔥4🤝6
the heart rate thing is real enough that i mention it whenever someone asks about starting
appetite suppression at 15 was stronger than my tirzepatide experience at a comparable point
❤️18
Testing queue: 9 submissions open, 108 awaiting dispatch.
👀1👍1
research use only
came off at 19 weeks because my resting rate stayed elevated and i didnt like it
blood pressure stayed flat for me while heart rate moved, which i didnt expect
does the glucagon arm explain the heart rate or is that unrelated
TRIUMPH is phase 3
fridge-temps.csv
436 rows · not retained in the public archive
whats the half life like, is it weekly the same way
there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists
anyone reconstituting 15 vials to 4 so the steps come out smaller
how slow is low and slow here, four weeks a step or longer
held mine ages
stepping in 5 increments instead of doubling is the only thing i would change if i started again
sat at 2.5 for 2 months rather than climbing and it kept working, so i never went up
research use only is on every vial and i treat it as exactly that, nobody here is prescribing, i have it written down somewhere
did the phase 2 plateau or was it still moving at the end
i went up too fast, got a fortnight of nothing but nausea, and dropped back two steps
triple agonist yeah
settled by month three
sorry to jump in GI was about the same as tirzepatide for me, the difference was how fast it arrived, ask me again in a month
glucagon is the new bit
anyone gone above 1.7 and what changed
❤️1
smaller steps here
logging rhr daily
peptidemeter-summary-c-4402.pdf
2 pages · 147 KB · not retained in the public archive
coming back to this phase 2 was still trending at the end which is why the phase 3 readout matters more than usual
triple agonist meaning GLP-1, GIP and glucagon, have i got that right
the honest position is this has less human evidence behind it than anything else discussed here, your mileage will differ
❤️18
does the energy expenditure claim show up as anything you can feel
weights-monthly.csv
279 rows · not retained in the public archive